Widespread adoption of SBRT has improved survival rates for elderly patients with early stage lung cancer
Tuesday, September 27, 2016 - 03:41
in Health & Medicine
Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research.